Abstract
Infections with the gram-negative bacteria Bordetella pertussis (B. pertussis) have long been recognized as a significant threat to children and are increasingly recognized as a cause of cough in adolescents and adults. Antibiotic therapy, when administered during the virulent stages of the disease, can reduce the duration and severity of symptoms. Unfortunately, there are no effective treatments for the persistent coughing that accompanies and follows the infection. The pathogenesis of B. pertussis infection is briefly reviewed. Also discussed is the evidence supporting the hypothesis that the inflammatory peptide bradykinin may be responsible for the persistent, paroxysmal coughing associated with B. pertussis-initiated illness.
Similar content being viewed by others
References
Hewlett EL, Edwards KM (2005) Clinical practice. Pertussis—not just for kids. N Engl J Med 352(12):1215–1222
Crowcroft NS, Pebody RG (2006) Recent developments in pertussis. Lancet 367(9526):1926–1936
Singh M, Lingappan K (2006) Whooping cough: the current scene. Chest 130(5):1547–1553
Brooks DA, Clover R (2006) Pertussis infection in the United States: role for vaccination of adolescents and adults. J Am Board Fam Med 19(6):603–611
Halperin SA (2007) The control of pertussis—2007 and beyond. N Engl J Med 356(2):110–113
Gogol EB, Cummings CA, Burns RC, Relman DA (2007) Phase variation and microevolution at homopolymeric tracts in Bordetella pertussis. BMC Genomics 8:122
Kallonen T, He Q (2009) Bordetella pertussis strain variation and evolution postvaccination. Expert Rev Vaccines 8(7):863–875
Altunaiji S, Kukuruzovic R, Curtis N, Massie J (2007) Antibiotics for whooping cough (pertussis). Cochrane Database Syst Rev (3):CD004404
Paddock CD, Sanden GN, Cherry JD, Gal AA, Langston C, Tatti KM, Wu KH, Goldsmith CS, Greer PW, Montague JL, Eliason MT, Holman RC, Guarner J, Shieh WJ, Zaki SR (2008) Pathology and pathogenesis of fatal Bordetella pertussis infection in infants. Clin Infect Dis 47(3):328–338
Braman SS (2006) Postinfectious cough: ACCP evidence-based clinical practice guidelines. Chest 129(1 Suppl):138S–146S
Pillay V, Swingler G (2003) Symptomatic treatment of the cough in whooping cough. Cochrane Database Syst Rev (4):CD003257
Carbonetti NH (2007) Immunomodulation in the pathogenesis of Bordetella pertussis infection and disease. Curr Opin Pharmacol 7(3):272–278
Relman DA, Domenighini M, Tuomanen E, Rappuoli R, Falkow S (1989) Filamentous hemagglutinin of Bordetella pertussis: nucleotide sequence and crucial role in adherence. Proc Natl Acad Sci USA 86(8):2637–2641
Luker KE, Collier JL, Kolodziej EW, Marshall GR, Goldman WE (1993) Bordetella pertussis tracheal cytotoxin and other muramyl peptides: distinct structure–activity relationships for respiratory epithelial cytopathology. Proc Natl Acad Sci USA 90(6):2365–2369
Joseph K, Kaplan AP (2005) Formation of bradykinin: a major contributor to the innate inflammatory response. Adv Immunol 86:159–208
Leeb-Lundberg LM, Marceau F, Müller-Esterl W, Pettibone DJ, Zuraw BL (2005) International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev 57(1):27–77
Abraham WM, Scuri M, Farmer SG (2006) Peptide and non-peptide bradykinin receptor antagonists: role in allergic airway disease. Eur J Pharmacol 533(1–3):215–221
Proud D (1998) The kinin system in rhinitis and asthma. Clin Rev Allergy Immunol 16(4):351–364
Proud D, Togias A, Naclerio RM, Crush SA, Norman PS, Lichtenstein LM (1983) Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen. J Clin Invest 72(5):1678–1685
Christiansen SC, Proud D, Cochrane CG (1987) Detection of tissue kallikrein in the bronchoalveolar lavage fluid of asthmatic subjects. J Clin Invest 79(1):188–197
Christiansen SC, Proud D, Sarnoff RB, Juergens U, Cochrane CG, Zuraw BL (1992) Elevation of tissue kallikrein and kinin in the airways of asthmatic subjects after endobronchial allergen challenge. Am Rev Respir Dis 145(4 Pt 1):900–905
Mansour E, Ahmed A, Cortes A, Caplan J, Burch RM, Abraham WM (1992) Mechanisms of metabisulfite-induced bronchoconstriction: evidence for bradykinin B2-receptor stimulation. J Appl Physiol 72(5):1831–1837
Ricciardolo FL, Nadel JA, Graf PD, Bertrand C, Yoshihara S, Geppetti P (1994) Role of kinins in anaphylactic-induced bronchoconstriction mediated by tachykinins in guinea-pigs. Br J Pharmacol 113(2):508–512
Coyle AJ, Ackerman SJ, Burch R, Proud D, Irvin CG (1995) Human eosinophil-granule major basic protein and synthetic polycations induce airway hyperresponsiveness in vivo dependent on bradykinin generation. J Clin Invest 95(4):1735–1740
Yoshihara S, Geppetti P, Hara M, Linden A, Ricciardolo FL, Chan B, Nadel JA (1996) Cold air-induced bronchoconstriction is mediated by tachykinin and kinin release in guinea pigs. Eur J Pharmacol 296(3):291–296
Grünberg K, Kuijpers EA, de Klerk EP, de Gouw HW, Kroes AC, Dick EC, Sterk PJ (1997) Effects of experimental rhinovirus 16 infection on airway hyperresponsiveness to bradykinin in asthmatic subjects in vivo. Am J Respir Crit Care Med 155(3):833–838
Ricciardolo FL, Rado V, Fabbri LM, Sterk PJ, Di Maria GU, Geppetti P (1999) Bronchoconstriction induced by citric acid inhalation in guinea pigs: role of tachykinins, bradykinin, and nitric oxide. Am J Respir Crit Care Med 159(2):557–562
Scuri M, Forteza R, Lauredo I, Sabater JR, Botvinnikova Y, Allegra L, Abraham WM (2000) Inhaled porcine pancreatic elastase causes bronchoconstriction via a bradykinin-mediated mechanism. J Appl Physiol 89(4):1397–1402
Folkerts G, Vlieger JW, de Vries A, Faas S, van Der Linde H, Engels F, de Jong JC, Verheyen FA, Van Heuven-Nolsen D, Nijkamp FP (2000) Virus- and bradykinin-induced airway hyperresponsiveness in guinea pigs. Am J Respir Crit Care Med 161(5):1666–1671
Turner P, Dear J, Scadding G, Foreman JC (2001) Role of kinins in seasonal allergic rhinitis: icatibant, a bradykinin B2 receptor antagonist, abolishes the hyperresponsiveness and nasal eosinophilia induced by antigen. J Allergy Clin Immunol 107(1):105–113
Effros RM, Dunning MB 3rd, Biller J, Shaker R (2004) The promise and perils of exhaled breath condensates. Am J Physiol Lung Cell Mol Physiol 287(6):L1073–L1080
Fox AJ, Lalloo UG, Belvisi MG, Bernareggi M, Chung KF, Barnes PJ (1996) Bradykinin-evoked sensitization of airway sensory nerves: a mechanism for ACE-inhibitor cough. Nat Med 2(7):814–817
Tom B, Dendorfer A, de Vries R, Saxena PR, Jan Danser AH (2002) Bradykinin potentiation by ACE inhibitors: a matter of metabolism. Br J Pharmacol 137(2):276–284
Dicpinigaitis PV (2006) Angiotensin-converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelines. Chest 129(1 Suppl):169S–173S
Jacoby DB (2002) Virus-induced asthma attacks. JAMA 287(6):755–761
Kaneko T, Stearns-Kurosawa DJ, Taylor F Jr, Twigg M, Osaki K, Kinasewitz GT, Peer G, Kurosawa S (2003) Reduced neutrophil CD10 expression in nonhuman primates and humans after in vivo challenge with E. coli or lipopolysaccharide. Shock 20(2):130–137
Casey L, Krieger B, Kohler J, Rice C, Oparil S, Szidon P (1981) Decreased serum angiotensin converting enzyme in adult respiratory distress syndrome associated with sepsis: a preliminary report. Crit Care Med 9(9):651–654
Choudry NB, Fuller RW, Pride NB (1989) Sensitivity of the human cough reflex: effect of inflammatory mediators prostaglandin E2, bradykinin, and histamine. Am Rev Respir Dis 140(1):137–141
Canning BJ, Mazzone SB, Meeker SN, Mori N, Reynolds SM, Undem BJ (2004) Identification of the tracheal and laryngeal afferent neurones mediating cough in anaesthetized guinea-pigs. J Physiol 557(Pt 2):543–558
El-Hashim AZ, Amine SA (2005) The role of substance P and bradykinin in the cough reflex and bronchoconstriction in guinea-pigs. Eur J Pharmacol 513(1–2):125–133
Mazzone SB, Mori N, Canning BJ (2005) Synergistic interactions between airway afferent nerve subtypes regulating the cough reflex in guinea-pigs. J Physiol 569(Pt 2):559–573
Arndt PG, Young SK, Poch KR, Nick JA, Falk S, Schrier RW, Worthen GS (2006) Systemic inhibition of the angiotensin-converting enzyme limits lipopolysaccharide-induced lung neutrophil recruitment through both bradykinin and angiotensin II-regulated pathways. J Immunol 177(10):7233–7241
Johnson AR, Ashton J, Schulz WW, Erdös EG (1985) Neutral metalloendopeptidase in human lung tissue and cultured cells. Am Rev Respir Dis 132(3):564–568
Sunday ME, Hua J, Torday JS, Reyes B, Shipp MA (1992) CD10/neutral endopeptidase 24.11 in developing human fetal lung. Patterns of expression and modulation of peptide-mediated proliferation. J Clin Invest 90(6):2517–2525
Johnson AM, Alper CA, Rosen FS, Craig JM (1971) C1 inhibitor: evidence for decreased hepatic synthesis in hereditary angioneurotic edema. Science 173(996):553–554
Stoppa-Lyonnet D, Tosi M, Laurent J, Sobel A, Lagrue G, Meo T (1987) Altered C1 inhibitor genes in type I hereditary angioedema. N Engl J Med 317(1):1–6
Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A (1998) Plasma bradykinin in angio-oedema. Lancet 351(9117):1693–1697
Han ED, MacFarlane RC, Mulligan AN, Scafidi J, Davis AE 3rd (2002) Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor. J Clin Invest 109(8):1057–1063
Bork K, Frank J, Grundt B, Schlattmann P, Nussberger J, Kreuz W (2007) Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant). J Allergy Clin Immunol 119(6):1497–1503
Temino VM, Peebles RS Jr (2008) The spectrum and treatment of angioedema. Am J Med 121(4):282–286
Marr N, Luu RA, Fernandez RC (2007) Bordetella pertussis binds human C1 esterase inhibitor during the virulent phase, to evade complement-mediated killing. J Infect Dis 195(4):585–588
Kirimanjeswara GS, Agosto LM, Kennett MJ, Bjornstad ON, Harvill ET (2005) Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis. J Clin Invest 115(12):3594–3601
Andreasen C, Carbonetti NH (2008) Pertussis toxin inhibits early chemokine production to delay neutrophil recruitment in response to Bordetella pertussis respiratory tract infection in mice. Infect Immun 76(11):5139–5148
Kenne E, Soehnlein O, Herwald H, Lindbom L (2009) Neutrophil-derived heparin binding protein (HBP) is an endogenous activator of the kallikrein-kinin system. FASEB J 23:762.3
Garcia JG, Wang P, Schaphorst KL, Becker PM, Borbiev T, Liu F, Birukova A, Jacobs K, Bogatcheva N, Verin AD (2002) Critical involvement of p38 MAP kinase in pertussis toxin-induced cytoskeletal reorganization and lung permeability. FASEB J 16(9):1064–1076
Camerer E, Regard JB, Cornelissen I, Srinivasan Y, Duong DN, Palmer D, Pham TH, Wong JS, Pappu R, Coughlin SR (2009) Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice. J Clin Invest 119(7):1871–1879
Proud D, Vio CP (1993) Localization of immunoreactive tissue kallikrein in human trachea. Am J Respir Cell Mol Biol 8(1):16–19
Tamaoki J, Takeyama K, Yamawaki I, Kondo M, Konno K (1997) Lipopolysaccharide-induced goblet cell hypersecretion in the guinea pig trachea: inhibition by macrolides. Am J Physiol 272(1 Pt 1):L15–L19
Forteza R, Lauredo I, Abraham WM, Conner GE (1999) Bronchial tissue kallikrein activity is regulated by hyaluronic acid binding. Am J Respir Cell Mol Biol 21(6):666–674
Yan F, Li W, Jono H, Li Q, Zhang S, Li JD, Shen H (2008) Reactive oxygen species regulate Pseudomonas aeruginosa lipopolysaccharide-induced MUC5AC mucin expression via PKC-NADPH oxidase-ROS-TGF-alpha signaling pathways in human airway epithelial cells. Biochem Biophys Res Commun 366(2):513–519
Herwald H, Mörgelin M, Olsén A, Rhen M, Dahlbäck B, Müller-Esterl W, Björck L (1998) Activation of the contact-phase system on bacterial surfaces—a clue to serious complications in infectious diseases. Nat Med 4(3):298–302
Lauredo IT, Forteza RM, Botvinnikova Y, Abraham WM (2004) Leukocytic cell sources of airway tissue kallikrein. Am J Physiol Lung Cell Mol Physiol 286(4):L734–L740
Imamura T, Kobayashi H, Khan R, Nitta H, Okamoto K (2006) Induction of vascular leakage and blood pressure lowering through kinin release by a serine proteinase from Aeromonas sobria. J Immunol 177(12):8723–8729
Moss J, Hom BE, Hewlett EL, Tsai SC, Adamik R, Halpern JL, Price SR, Manganiello VC (1988) Mechanism of enhanced sensitivity to bradykinin in pertussis toxin-treated fibroblasts: toxin increases bradykinin-stimulated prostaglandin formation. Mol Pharmacol 34(3):279–285
Fujimoto M, Sakata T, Tsuruta Y, Iwagami S, Teraoka H, Mihara S, Fukiishi Y, Ide M (1990) Enhancement of bradykinin-induced prostacyclin synthesis in porcine aortic endothelial cells by pertussis toxin. Possible implication of lipocortin I. Biochem Pharmacol 40(12):2661–2670
Wolsing DH, Rosenbaum JS (1993) The mechanism for the rapid desensitization in bradykinin-stimulated inositol monophosphate production in NG108-15 cells involves interaction of a single receptor with multiple signaling pathways. J Pharmacol Exp Ther 266(1):253–261
Kozaki Y, Kambe F, Hayashi Y, Ohmori S, Seo H, Kumazawa T, Mizumura K (2007) Molecular cloning of prostaglandin EP3 receptors from canine sensory ganglia and their facilitatory action on bradykinin-induced mobilization of intracellular calcium. J Neurochem 100(6):1636–1647
Morice AH, Lowry R, Brown MJ, Higenbottam T (1987) Angiotensin-converting enzyme and the cough reflex. Lancet 2(8568):1116–1118
Katsumata U, Sekizawa K, Ujiie Y, Sasaki H, Takishima T (1991) Bradykinin-induced cough reflex markedly increases in patients with cough associated with captopril and enalapril. Tohoku J Exp Med 164(2):103–109
Morice AH, Turley AJ, Linton TK (1997) Human ACE gene polymorphism and distilled water induced cough. Thorax 52(2):111–113
Wood N, McIntyre P (2008) Pertussis: review of epidemiology, diagnosis, management and prevention. Paediatr Respir Rev 9(3):201–211
Kajekar R, Proud D, Myers AC, Meeker SN, Undem BJ (1999) Characterization of vagal afferent subtypes stimulated by bradykinin in guinea pig trachea. J Pharmacol Exp Ther 289(2):682–687
Carr MJ, Kollarik M, Meeker SN, Undem BJ (2003) A role for TRPV1 in bradykinin-induced excitation of vagal airway afferent nerve terminals. J Pharmacol Exp Ther 304(3):1275–1279
Kollarik M, Undem BJ (2004) Activation of bronchopulmonary vagal afferent nerves with bradykinin, acid and vanilloid receptor agonists in wild-type and TRPV1−/− mice. J Physiol 555(Pt 1):115–123
Lee MG, Macglashan DW Jr, Undem BJ (2005) Role of chloride channels in bradykinin-induced guinea pig airway vagal C-fibre activation. J Physiol 566(Pt 1):205–212
Acknowledgments
This work was supported by a grant from the National Institutes of Health (HL083192).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hewitt, M., Canning, B.J. Coughing Precipitated by Bordetella pertussis Infection. Lung 188 (Suppl 1), 73–79 (2010). https://doi.org/10.1007/s00408-009-9196-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00408-009-9196-9